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	 Which	risk	factors	and	signs	
and	symptoms	are	associated	
with	coccidioidomycosis?	
	 Risk factors	for	coccidioidomyco-
	 sis,	 or	 valley	 fever,	 include	 lower	
respiratory	 tract	 symptoms	 lasting	 lon-
ger	 than	 14	 days,	 chest	 pain,	 rash,	 hav-
ing	 lived	 in	 endemic	 areas	 fewer	 than	
10	 years,	 and	 diabetes	 mellitus	 or	 im-
munosuppressive	 conditions	 (strength	
of	 recommendation	 [SOR]:	 B,	 several	
prospective	 cohort	 and	 case-control	
studies).
The	 most	 common	 signs	 and	 symp-
toms	 include	 cough	 (74%),	 fever	 (56%),	
night	 sweats	 (35%),	 pleuritic	 chest	 pain	
(33%),	chills	(28%),	dyspnea	(27%),	weight	
loss	(21%),	and	rash	(14%)	(SOR:	B,	retro-
spective	cohort	study).
Evidence summary
A	2013	surveillance	report	by	the	Centers	for	
Disease	Control	and	Prevention	that	included	
111,717	patients	in	28	states	and	the	District	
of	Columbia	 found	an	8-fold	 increase	 in	 re-
ported	coccidioidomycosis	in	endemic	areas	
from	 1998	 to	 2011	 (age-adjusted	 incidence	
rates:	 5.3	 per	 100,000	 in	 1998	 and	 42.6	 per	
100,000	in	2011).	Cases	in	nonendemic	states	
increased	 40-fold	 in	 the	 same	 time	 period,	
from	6	cases	to	240.1	The	disease	is	endemic	
in	the	southwest	United	States	and	northwest	
Mexico.	
Risk factors include persistent symptoms, 
chest pain, diabetes, immunosuppression
A	2008	case-control	study	of	136	patients	 in	
Phoenix,	 Arizona	 (an	 endemic	 area)	 found	
that	 15%	 of	 the	 patients	 diagnosed	 with	
community-acquired	 pneumonia	 (CAP)	
had	coccidioidomycosis	on	serologic	testing.	
Risk	 factors	 for	CAP	caused	by	coccidioido-
mycosis	 in	 this	 population	 were	 symptom	
duration	 longer	 than	 14	 days	 (odds	 ratio	
[OR]=5.0;	 95%	 confidence	 interval	 [CI],	 2.1-
15.7),	 age	 younger	 than	 18	 years	 (OR=5.5;	
95%	 CI,	 2.1-15.3),	 chest	 pain	 (OR=4.6;	 95%	
CI,	1.8-11.8),	and	diabetes	mellitus	or	an	im-
munosuppressive	 condition	 (OR=3.8;	 95%	
CI,	1.0-16.5).2	
Abnormal chest X-rays, myalgia— 
and a rash
A	2006	prospective	cohort	study	of	55	patients	
in	Tucson,	Arizona,	which	 is	part	of	 the	en-
demic	area,	found	that	29%	of	patients	diag-
nosed	with	CAP	tested	serologically	positive	
for	coccidioidomycosis.	Risk	factors	included	
fewer	than	10	years	of	exposure	to	an	endem-
ic	area	(OR=4.11;	95%	CI,	1.01-16.8).	Chest	ra-
diograph	abnormalities	were	more	common	
in	 patients	 with	 CAP	 caused	 by	 coccidioi-
domycosis	 than	 patients	 without	 coccidioi-
domycosis	 (75%	 vs	 25%,	P=.005).	Myalgia	 is	
more	 common	when	 coccidioidal	 pneumo-
nia	is	present	(69%	vs	23%,	P=.0022).3
A	 2009	 prospective	 cohort	 study	 of	
35	 patients	 with	 CAP	 in	 Phoenix,	 Arizona	
found	 that	 6	 patients	 (17%)	 tested	 positive	
for	 coccidioidomycosis.	 Only	 1	 statistically	
significant	risk	 factor	was	 identified—half	of	
patients	with	coccidioidomycosis	exhibited	a	
rash,	while	there	were	no	rashes	in	the	group	
without	the	disease	(P=.002).4	
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Other common signs and symptoms
A	 retrospective	 cohort	 study	 in	 San	 Diego,	
California	 in	 2004	 evaluated	 and	 stratified	
223	 patients	 with	 known	 coccidioidomycosis	
for	presenting	symptoms,	exam	findings,	and	
radiographic	findings.	The	most	common	signs	
and	 symptoms	at	 time	of	 seropositive	 testing	
were	 cough	 (74%),	 fever	 (56%),	 night	 sweats	
(35%),	pleuritic	chest	pain	(33%),	chills	(28%),	
weight	loss	(21%),	rash	(14%),	and	arthralgia	or	
myalgia	(13%	and	12%,	respectively).5	
Airspace	opacity	was	the	most	common	
radiographic	 abnormality	 (58.8%);	 the	 sec-
ond	most	 common	was	pulmonary	nodules	
(22.8%).5	The	 study	 didn’t	 compare	 the	 fre-
quency	of	 these	findings	with	noncoccidioi-
dal	pneumonia.	
Recommendations
In	 2005	 guidelines,	 the	 Infectious	 Diseases	
Society	 of	 America	 (IDSA)	 stated	 that	 the	
“management	of	coccidioidomycosis	first	in-
volves	 recognizing	 that	a	 coccidioidal	 infec-
tion	 exists,	 defining	 the	 extent	 of	 infection,	
and	 identifying	 host	 factors	 that	 predispose	
to	 disease	 severity.”6	 The	 IDSA	 didn’t	 give	
specific	 recommendations	 regarding	how	 to	
diagnose	 or	 differentiate	 coccidioidal	 infec-
tion	from	CAP.		 	 	 													JFP
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